Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Wiehle

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Gene Therapy|June 10, 2006
A multifunctional PEI-based cationic polyplex for enhanced systemic p53-mediated gene therapyS Moffatt, S Wiehle, R J Cristiano
Gene Therapy|February 3, 2006
Successful in vivo tumor targeting of prostate-specific membrane antigen with a highly efficient J591/PEI/DNA molecular conjugateS Moffatt, C Papasakelariou, S Wiehle, et al.
Gene Therapy|February 4, 1999
The contribution of poly-L-lysine, epidermal growth factor and streptavidin to EGF/PLL/DNA polyplex formationB Xu, S Wiehle, J A Roth, et al.
Oncogene|March 29, 2000
Down-regulation of bcl-2 is associated with p16INK4-mediated apoptosis in non-small cell lung cancer cellsM Kataoka, S Wiehle, F Spitz, et al.
Oncogene|September 12, 2000
Insulin-like growth factor binding protein-6 activates programmed cell death in non-small cell lung cancer cellsN Sueoka, H Y Lee, S Wiehle, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 15, 1994
In vivo hepatic gene therapy: complete albeit transient correction of factor IX deficiency in hemophilia B dogsM A Kay, C N Landen, S R Rothenberg, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Gene Therapy|June 10, 2006
A multifunctional PEI-based cationic polyplex for enhanced systemic p53-mediated gene therapyS Moffatt, S Wiehle, R J Cristiano
Gene Therapy|February 3, 2006
Successful in vivo tumor targeting of prostate-specific membrane antigen with a highly efficient J591/PEI/DNA molecular conjugateS Moffatt, C Papasakelariou, S Wiehle, et al.
Gene Therapy|February 4, 1999
The contribution of poly-L-lysine, epidermal growth factor and streptavidin to EGF/PLL/DNA polyplex formationB Xu, S Wiehle, J A Roth, et al.
Oncogene|March 29, 2000
Down-regulation of bcl-2 is associated with p16INK4-mediated apoptosis in non-small cell lung cancer cellsM Kataoka, S Wiehle, F Spitz, et al.
Oncogene|September 12, 2000
Insulin-like growth factor binding protein-6 activates programmed cell death in non-small cell lung cancer cellsN Sueoka, H Y Lee, S Wiehle, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 15, 1994
In vivo hepatic gene therapy: complete albeit transient correction of factor IX deficiency in hemophilia B dogsM A Kay, C N Landen, S R Rothenberg, et al.
Pageof 1